ACADEMIC AND RESEARCH PEER-REVIEWED MEDICAL JOURNALISSN 1727-2378 (Print)         ISSN 2713-2994 (Online)
Ru
En

Clinical Significance of Collateral Coronary Blood Flow in Patients with Ischemic Heart Disease

Bibliography link: E. V. Kozlova, I. V. Starostin, O. S. Bulkina, V. V. Lopukhova, Yu. A. Karpov. Clinical Significance of Collateral Coronary Blood Flow in Patients with Ischemic Heart Disease // Doctor.Ru. 2016; №11(128): 17–22.
13 December 00:00

Objective of the Review: To summarize the data of published studies that evaluated the role of collateral blood flow in ischemic heart disease (IHD), associated factors, and potential ways to change such blood flow.

Key Points: In patients with IHD, collateral blood flow is a natural way to compensate disturbed blood supply to ischemic myocardium. In these patients, good collateral blood flow is associated with a better prognosis. Many modifying and non-modifying factors that contribute to the development of collateral flow have been identified. Methods that would change collateral circulation are now being developed.

Conclusion: Studies aimed to find safe and effective ways to improve collateral blood flow in patients with IHD should be continued.

E. V. Kozlova — Russian Cardiology Research and Production Complex, Moscow. E-mail: ekaterinavkozlova@yandex.ru

I. V. Starostin — Russian Cardiology Research and Production Complex, Moscow. E-mail: ivs_01@bk.ru

O. S. Bulkina — Russian Cardiology Research and Production Complex, Moscow. E-mail: olgabulkina@mail.ru

V. V. Lopukhova — Russian Cardiology Research and Production Complex, Moscow. E-mail: trialvvl@mail.ru

Yu. A. Karpov — Russian Cardiology Research and Production Complex, Moscow. E-mail: Yuri_Karpov@inbox.ru


Доктор.ру
13 December 00:00
LITERATURE
  1. Всемирная организация здравоохранения. Сердечно-сосудистые заболевания. URL: http://www.who.int/cardiovascular_diseases/ru (дата обращения — 15.09.2016).
  2. Парфенова Е. В., Ткачук В. А. Терапевтический ангиогенез: достижения, проблемы, перспективы // Кардиол. вестн. 2007. Т. 2. № 2. URL: http://old.consilium-medicum.com/media/cardio/07_02/5.shtml (дата обращения — 15.09.2016).
  3. Старостин И. В. Клинико-лабораторные, генетические и ангиографические факторы, ассоциированные с особенностями коллатерального кровотока у больных ишемической болезнью сердца: Автореф. дис. … канд. мед. наук. М., 2015. 25 с.
  4. Старостин И. В., Талицкий К. А., Булкина О. С., Парфенова Е. В. и др. Коллатеральный кровоток в миокарде: роль фактора роста эндотелия сосудов // Кардиология. 2012. № 11. С. 49–55.
  5. Старостин И. В., Талицкий К. А., Булкина О. С., Самко А. Н. и др. Коллатеральный кровоток и функциональное состояние миокарда у больных хронической ишемической болезнью сердца // Кадиол. вестн. 2015. Т. 10. № 1. С. 31–36.
  6. Abawi M., Nijhoff F., Stella P. R., Voskuil M. et al. Safety and efficacy of a device to narrow the coronary sinus for the treatment of refractory angina: a single-centre real-world experience // Neth. Heart J. 2016. Vol. 24. N 9. P. 544–551.
  7. Akin S., Yetgin T., Brugts J. J., Dirkali A. et al. Effect of collaterals on deaths and re-infarctions in patients with coronary artery disease: a meta-analysis // Neth. Heart J. 2013. Vol. 21. N 3. P. 146–151.
  8. Altin T., Kilickap M., Tutar E., Turhan S. et al. The relationship of chronic angiotensin converting enzyme inhibitor use and coronary collateral vessel development // Int. Heart J. 2007. Vol. 48. N 4. P. 435–442.
  9. Antoniucci D., Valenti R., Moschi G., Migliorini A. et al. Relation between preintervention angiographic evidence of coronary collateral circulation and clinical and angiographic outcomes after primary angioplasty or stenting for acute myocardial infarction // Am. J. Cardiol. 2002. Vol. 89. N 2. P. 121–125.
  10. Arslan U., Kocaoğlu İ., Falay M. Y., Balci M. et al. The association between different monocyte subsets and coronary collateral development // Coron. Artery Dis. 2012. Vol. 23. N 1. P. 16–21.
  11. Balli M., Çetin M., Taşolar H., Uysal O. K. et al. The relationship between serum thyroid hormone levels, subclinical hypothyroidism, and coronary collateral circulation in patients with stable coronary artery disease // Turk. Kardiyol. Dern. Ars. 2016. Vol. 44. N 2. P. 130–136.
  12. Banai S., Ben Muvhar S., Parikh K. H., Medina A. et al. Coronary sinus reducer stent for the treatment of chronic refractory angina pectoris: a prospective, open-label, multicenter, safety feasibility first-in-man study // J. Am. Coll. Cardiol. 2007. Vol. 49. N 17. P. 1783–1789.
  13. Billinger M., Kloos P., Eberli F. R., Windecker S. et al. Physiologically assessed coronary collateral flowand adverse cardiac ischemic events: a follow-up study in 403 patients with coronary artery disease // J. Am. Coll. Cardiol. 2002. Vol. 40. N 9. P. 1545–1550.
  14. Buschmann E. E., Utz W., Pagonas N., Schulz-Menger J. et al. Improvement of fractional flow reserve and collateral flow by treatment with external counterpulsation (Art.Net.-2 Trial) // Eur. J. Clin. Invest. 2009. Vol. 39. N 10. P. 866–875.
  15. Buschmann I. R., Heil M., Jost M., Schaper W. Influence of inflammatory cytokines on arteriogenesis // Microcirculation. 2003. Vol. 10. N 3–4. P. 371–379.
  16. Ceyhan K., Kadi H., Celik A., Burucu T. et al. Angiotensin-converting enzyme DD polymorphism is associated with poor coronarycollateral circulation in patients with coronary artery disease // J. Investig. Med. 2012. Vol. 60. N 1. P. 49–55.
  17. de Marchi S. F. Determinants of human coronary collaterals // Curr. Cardiol. Rev. 2014. Vol. 10. N 1. P. 24–28.
  18. Degen A., Millenaar D., Schirmer S. H. Therapeutic approaches in the stimulation of the coronary collateral circulation // Curr. Cardiol. Rev. 2014. Vol. 10. N 1. P. 65–72.
  19. Dincer I., Ongun A., Turhan S., Ozdol C. et al. Association between the dosage and duration of statin treatment with coronary collateral development // Coron. Artery Dis. 2006. Vol. 17. N 6. P. 561–565.
  20. Dincer I., Ongun A., Turhan S., Ozdol C. et al. Effect of statin treatment on coronary collateral development in patients with diabetes mellitus // Am. J. Cardiol. 2006. Vol. 97. N 6. P. 772–774.
  21. Duran J., Olavarría P. S., Mola M., Götzens V. et al. Genetic association study of coronary collateral circulation in patients with coronary artery disease using 22 single nucleotide polymorphisms corresponding to 10 genes involved in post-ischemic neovascularization // BMC Cardiovasc. Disord. 2015. Vol. 15. P. 37.
  22. Duran J., Sánchez-Olavarría P., Mola M., Götzens V. et al. The PLAU P141L single nucleotide polymorphism is associated with collateral circulation in patients with coronary artery disease // Rev. Esp. Cardiol. 2014. Vol. 67. N 7. P. 552–557.
  23. Faber J. E. Reprogrammed endothelial cells: cell therapy for coronary collateral growth? // Circ. Res. 2012. Vol. 110. N 2. P. 192–194.
  24. Faber J. E., Chilian W. M., Deindl E., van Royen N. et al. A brief etymology of the collateral circulation // Arterioscler. Thromb. Vasc. Biol. 2014. Vol. 34. N 9. P. 1854–18549.
  25. Fan Y., Li S., Li X. L., Lin X. L. et al. Plasma endothelin-1 level as a predictor for poor collaterals in patients with ≥ 95% coronary chronic occlusion // Thromb. Res. 2016. Vol. 142. P. 21–25.
  26. Gloekler S., Meier P., de Marchi S. F., Rutz T. et al. Coronary collateral growth by external counterpulsation: a randomised controlled trial // Heart. 2010. Vol. 96. N 3. P. 202–207.
  27. Hakimzadeh N., Nossent A. Y., van der Laan A. M., Schirmer S. H. et al. Circulating microRNAs characterizing patients with insufficient coronary collateral artery function // PLoS One. 2015. Vol. 10. N 9: e0137035.
  28. Ishihara M., Fujita M., Obara K., Hattori H. et al. Controlled releases of FGF-2 and paclitaxel from chitosan hydrogels and their subsequent effects on wound repair, angiogenesis, and tumor growth // Curr. Drug Deliv. 2006. Vol. 3. N 4. P. 351–358.
  29. Karahan Z., Altıntaş B., Uğurlu M., Kaya İ. et al. The association between prolongation in QRS duration and presence of coronary collateral circulation in patients with acute myocardial infarction // JRSM Cardiovasc. Dis. 2016. Vol. 5. URL: http://cvd.sagepub.com/content/5/2048004016657475.full.pdf+html (дата обращения — 15.09.2016).
  30. Kim E. K., Choi J. H., Song Y. B., Hahn J. Y. et al. A protective role of early collateral blood flow in patients with ST-segment elevation myocardial infarction // Am. Heart J. 2016. Vol. 171. N 1. P. 56–63.
  31. Lenihan D. J., Osman A., Sriram V., Aitsebaomo J. et al. Evidence for association of coronary sinus levels of hepatocyte growth factor and collateralization in human coronary disease // Am. J. Physiol. Heart Circ. Physiol. 2003. Vol. 284. N 5. P. H1507–1512.
  32. Lu F., Zhao X., Wu J., Cui Y. et al. MSCs transfected with hepatocyte growth factor or vascular endothelial growth factor improve cardiac function in the infarcted porcine heart by increasing angiogenesis and reducing fibrosis // Int. J. Cardiol. 2013. Vol. 167. N 6. P. 2524–2532.
  33. Meier P., Gloekler S., Zbinden R., Beckh S. et al. Beneficial effect of recruitable collaterals a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements // Circulation. 2007. Vol. 116. N 9. P. 975–983.
  34. Meier P., Hemingway H., Lansky A. J., Knapp G. et al. The impact of the coronary collateral circulation on mortality: a meta-analysis // Eur. Heart J. 2012. Vol. 33. N 5. P. 614–621.
  35. Meier P., Indermuehle A., Pitt B., Traupe T. et al. Coronary collaterals and risk for restenosis after percutaneous coronary interventions: a meta-analysis // BMC Med. 2012. Vol. 10. P. 62.
  36. Möbius-Winkler S., Uhlemann M., Adams V., Sandri M. et al. Coronary collateral growth induced by physical exercise: results of the impact of intensive Exercise Training on Coronary Collateral Circulation in Patients With Stable Coronary Artery Disease (EXCITE) Trial // Circulation. 2016. Vol. 133. N 15. P. 1438–1448.
  37. Pérez-Castellano N., García E. J., Abeytua M., Soriano J. et al. Influence of collateral circulation on in-hospital death from anterior acute myocardial infarction // J. Am. Coll. Cardiol. 1998. Vol. 31. N 3. P. 512–518.
  38. Rentrop K. P., Cohen M., Blanke H., Phillips R. A. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects // J. Am. Coll. Cardiol. 1985. Vol. 5. N 3. P. 587–592.
  39. Sakakibara Y., Tambara K., Sakaguchi G., Lu F. et al. Toward surgical angiogenesis using slow-released basic fibroblast growth factor // Eur. J. Cardiothorac. Surg. 2003. Vol. 24. N 1. P. 105–111.
  40. Seiler C., Stoller M., Pitt B., Meier P. The human coronary collateral circulation: development and clinical importance // Eur. Heart J. 2013. Vol. 34. N 34. P. 2674–2682.
  41. Sharma U., Ramsey H. K., Tak T. The role of enhanced external counter pulsation therapy in clinical practice // Clin. Med. Res. 2013. Vol. 11. N 4. P. 226–232.
  42. Stuijfzand W. J., Driessen R. S., Raijmakers P. G., Rijnierse M. T. et al. Prevalence of ischaemia in patients with a chronic total occlusion and preserved left ventricular ejection fraction // Eur. Heart J. Cardiovasc. Imaging. 2016. PII: jew188.
  43. Tenekecioglu E., Yılmaz M., Karaagac K., Bekler A. et al. Predictors of coronary collaterals in patients with non ST-elevated acute coronary syndrome: the paradox of the leukocytes // Cent. Eur. J. Immunol. 2014. Vol. 39. N 1. P. 83–90.
  44. van der Hoeven N. W., Teunissen P. F., Werner G. S., Delewi R. et al. Clinical parameters associated with collateral development in patients with chronic total coronary occlusion // Heart. 2013. Vol. 99. N 15. P. 1100–1105.
  45. Verheye S., Jolicœur E. M., Behan M. W., Pettersson T. et al. Efficacy of a device to narrow the coronary sinus in refractory angina // N. Engl. J. Med. 2015. Vol. 372. N 6. P. 519–527.
  46. Wang W., Yang Z. J., Ma D. C., Wang L. S. et al. Induction of collateral artery growth and improvement of post-infarct heart function by hepatocyte growth factor gene transfer // Acta Pharmacol. Sin. 2006. Vol. 27. N 5. P. 555–556.
  47. Yang C., Han X., Jiang X., Lei X. et al. Relation between C-X-C motif chemokine receptor 4 levels and the presence and extent of angiographic coronary collaterals in patients with chronic total coronary occlusion // Am. J. Cardiol. 2016. Vol. 118. N 8. P. 1136–1143.
  48. Yang Z. J., Xu S. L., Chen B., Zhang S. L. et al. Hepatocyte growth factor plays a critical role in the regulation of cytokine production and induction of endothelial progenitor cell mobilization: a pilot gene therapy study in patients with coronary heart disease // Clin. Exp. Pharmacol. Physiol. 2009. Vol. 36. N 8. P. 790–796.
  49. Yin L., Ohanyan V., Pung Y. F., Delucia A. et al. Induction of vascular progenitor cells from endothelial cells stimulates coronary collateral growth // Circ. Res. 2012. Vol. 110. N 2. P. 241–252.
Новости мировой медицины! Свежие статьи из журнала! Будьте в курсе!

Похожие статьи

Similar article
19 April 00:00, Interview
Interview
Doctor.Ru Pediatrics. Vol. 20, No. 3 (2021)
19 April 00:00, Paediatrics
A.V. Aksenov, E.A. Ivanovskaya
Successful Use of Tocilizumab in a Child with Systemic Juvenile Idiopathic Arthritis
Doctor.Ru Pediatrics. Vol. 20, No. 3 (2021)

News